You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 6, JUNE 1966 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Carcinoid Syndrome With Gastric Hypersecretion and Histaminuria

DOUGLAS B. McGILL, MD; H. ROYDEN JONES, JR., MD

Arch Intern Med. 1966;117(6):784-788.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

STUDY of the systemic manifestations of malignant tumors has resulted in the delineation of a wide variety of syndromes.1 In many instances the tumors probably manufacture substances that have endocrine-like activity. Although rather specific syndromes were described initially, further case reports indicate more complex interrelationships among syndromes. The metastatic carcinoid tumor illustrates the diverse biochemical potential of the malignant cell. Biörck and associates2 in 1952 first described the clinical picture; Thorson3 in 1958, summarizing the literature to that time, described a rather characteristic syndrome of diarrhea and flushing that was sometimes associated with cardiac lesions and bronchial constriction. Central to this syndrome are hepatic metastases from carcinoid tumors producing high levels of various indoles in the serum and urine.4,5 Since 1958, many cases have been described that are atypical in respect to clinical symptoms, biochemical findings, and tissue of origin. These tumors are often associated with other "endocrine" tumors.8,7 The . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN

From the Mayo Clinic and Mayo Foundation: Section of Medicine (Dr. McGill). Mayo Graduate School of Medicine (University of Minnesota), Rochester (Dr. Jones).


Footnotes

Received for publication Sept 29, 1965; accepted March 28, 1966.

Reprint requests to Mayo Clinic, 200 First St SW, Rochester, Minn 55901.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1966 American Medical Association. All Rights Reserved.